Ribavirin suppresses replication of lymphadenopathy-associated virus in cultures of human adult T lymphocytes

scientific article published on December 15, 1984

Ribavirin suppresses replication of lymphadenopathy-associated virus in cultures of human adult T lymphocytes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0140-6736(84)92060-9
P953full work available at URLhttps://api.elsevier.com/content/article/PII:S0140673684920609?httpAccept=text/plain
https://api.elsevier.com/content/article/PII:S0140673684920609?httpAccept=text/xml
P698PubMed publication ID6150368

P50authorJoseph B. McCormickQ6281236
P2093author name stringD. R. Hicks
J. P. Getchell
S. W. Mitchell
P2860cites workIsolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Q22242256
Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDSQ29614260
Acquired immune deficiency syndrome in the United States: the first 1,000 casesQ34264271
Acquired immunodeficiency syndrome in a heterosexual population in ZaireQ39357879
The broad spectrum antiviral agent ribavirin inhibits capping of mRNAQ40257383
Ribavirin small-particle aerosol treatment of influenzaQ40850389
Design, synthesis, and broad spectrum antiviral activity of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosidesQ42232008
Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind studyQ44603480
Isolation of new lymphotropic retrovirus from two siblings with haemophilia B, one with AIDSQ44866062
National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men: Part 2. Laboratory resultsQ45041492
Lymphadenopathy Associated Virus Infection of a Blood Donor—Recipient Pair with Acquired Immunodeficiency SyndromeQ45796469
P433issue8416
P407language of work or nameEnglishQ1860
P921main subjectribavirinQ421862
clinical researchQ5133849
P304page(s)1367-1369
P577publication date1984-12-01
1984-12-15
P1433published inThe LancetQ939416
P1476titleRibavirin suppresses replication of lymphadenopathy-associated virus in cultures of human adult T lymphocytes
P478volume2

Reverse relations

cites work (P2860)
Q246092153'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro
Q34728008A guide to the investigation and treatment of patients with AIDS and AIDS-related disorders
Q42364568AIDS and taurolin
Q39755536Acquired immunodeficiency syndrome of childhood
Q69857527Antimoniotungstate (HPA 23) treatment of three patients with AIDS and one with prodrome
Q44036228Antiretroviral therapy and immunologic reconstitution in AIDS.
Q39479188Antiviral drugs for AIDS. Current status and future prospects
Q55243682Antiviral strategies and vaccines against HTLV III/LAV.
Q39152916Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date
Q38709585Antiviral therapy in human immunodeficiency virus infection
Q36070394Antiviral therapy: current concepts and practices
Q30047670Chemotherapeutics
Q36787397Clinical presentation and management of suspected ribavirin toxicosis in a dog
Q39659099Clinical review of ribavirin.
Q34104620Cyclosporine-induced deterioration in patients with AIDS.
Q28338199Effect of retinoic acid on the replication of human immunodeficiency virus in HTLV-I-positive MT-4 cells
Q36867854Expression of reverse transcriptase activity of human T-lymphotropic virus type III (HTLV-III/LAV) in Escherichia coli
Q45752014Hepatitis C in the patient with human immunodeficiency virus infection
Q40104175Homologous interference of lymphocytic choriomeningitis virus involves a ribavirin-susceptible block in virus replication.
Q53548434In search of specific inhibitors of retrovirus replication.
Q36215117In vitro and in vivo effects of ribavirin on human respiratory epithelium
Q37408000In vitro modification of human immunodeficiency virus infection by granulocyte-macrophage colony-stimulating factor and gamma interferon
Q28336184Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate
Q39851761Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro
Q28360374Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides
Q24619823Inhibitory effect of 2',3'-didehydro-2',3'-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus
Q39758125Management of infectious and immunological complications of acquired immunodeficiency syndrome (AIDS). Current and future prospects
Q28360109Marked in vivo antiretrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine, a selective anti-human immunodeficiency virus agent
Q41578932Metabolism and mode of selective inhibition of human immunodeficiency virus replication by 3'-azido-2',3'-dideoxy-5-iodouridine and 3'-azido-2',3'-dideoxy-5-bromouridine
Q27486816Molecular Mechanism of Hepatitis C Virus Replicon Variants with Reduced Susceptibility to a Benzofuran Inhibitor, HCV-796
Q39692591Pathogenesis of human immunodeficiency virus infection and prospects for control
Q35289449Pharmacokinetics of ribavirin aerosol in mice
Q55245135Recombinant human interferon alfa-A suppresses HTLV-III replication in vitro.
Q36008885Ribavirin and lethal mutagenesis of poliovirus: molecular mechanisms, resistance and biological implications
Q28361577Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitro
Q28337829Ribavirin antagonizes the effect of azidothymidine on HIV replication
Q50590208Ribavirin for HIV
Q39505179Ribavirin: a clinical overview
Q35810419Safety, tolerance, and pharmacokinetics of systemic ribavirin in children with human immunodeficiency virus infection
Q38172146Strategies for antiviral therapy in AIDS.
Q28340298Susceptibility of human immunodeficiency virus type 1 replication in vitro to acyclic adenosine analogs and synergy of the analogs with 3'-azido-3'-deoxythymidine
Q28338307Synergistic activity of granulocyte-macrophage colony-stimulating factor and 3'-azido-3'-deoxythymidine against human immunodeficiency virus in vitro
Q39563538The future of antiviral chemotherapy
Q28344154The ribavirin analog ICN 17261 demonstrates reduced toxicity and antiviral effects with retention of both immunomodulatory activity and reduction of hepatitis-induced serum alanine aminotransferase levels
Q33493051Toxicologic effects of ribavirin in cats
Q33740357Treatment of human immunodeficiency virus infections
Q38163930Treatment of the acquired immune deficiency syndrome
Q43848549Unique T-cell immune abnormalities in the development of acquired immune deficiency syndrome (AIDS).
Q24676814Visna virus as an in vitro model for human immunodeficiency virus and inhibition by ribavirin, phosphonoformate, and 2',3'-dideoxynucleosides
Q55245082[AIDS and HTLV-III in West Germany: the status February 1985].

Search more.